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1. Introduction 
Vitamin Ds is metabolized in the course of two 
hydroxylations: the first, in the liver, yields 
25-(OH)D3; the second, in the kidney, takes place in 
positions la and 24 and produces 1,25(OH),Ds and 
24,25-(0H)zDs. However, the kidney is probably not 
the sole production site for the latter sterol, since we 
demonstrated that cultured chondrocytes and cartilage 
tissue in vitro transform 25(OH)Ds into 24,25- 
(OH),D, [ 11. The biological effect of this last 
dihydroxylated metabolite is not yet clear, but we 
showed earlier that in cultured chondrocytes, 24,25- 
(OH)2D3 stimulates both the synthesis and secretion 
of proteoglycans [2] as well as DNA polymerase 
activities [3]. Such stimulation was obtained with 
24,25(OH)2Ds at lo-” M, suggesting that this 
metabolite is intrinsically active in chondrocytes at 
physiological concentrations. These results were the 
first in vitro demonstration that, at least in cartilage, 
24,25-(OH)2D3 is an active vitamin D metabolite 
rather than a product of degradation. In that case, the 
action of 24,25-(bH),Ds in chondrocytes might 
resemble that of other steroids in their target cells. 
Such cellular action involves temperature-dependent 
nuclear penetration of the sterol that precedes sterol- 
specific mRNA synthesis. 
With this in mind, we looked for nuclear penetra- 
tion of 24,25-(0H)2 [‘HID, using the above cultured 
chondrocyte model. 
Abbreviations: 25(OH)D,, 25hydroxyvitamin D,; 
1,25-(OH),D,, lq25dihydroxyvitamin D,; 24,25-(OH),D,, 
24,25dihydroxyvitamin D,; 24,25-(OH), [3H]D3, tritiated 
24,25-(OH),D,; 25-(OH)[‘H]D,, tritiated 25-(OH)D,; FCS, 
fetal calf serum; GBS, Gey’s buffer solution 
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2. Materials and methods 
The general scheme of the experiments was as fol- 
lows: chondrocyte cultures were started after enzyme 
digestion of 300 g rabbit growth plate cartilage. The 
tibiae were microdissected under sterile conditions 
and digested with 0.2% Trypsin (Worthington) and 
0.2% clostridial collagenase (Boehringer) in GBS. 
Large culture flasks (75 cm’) were inoculated with 
the chondrocyte suspension thus obtained (3.5 X 10’ 
cells/flask) and cultured as in [4]. Each flask con- 
tained 14 ml Dulbecco’s medium (Gibco-Flobio) sup- 
plemented with 10% FCS, 0.1 unit/ml penicillin and 
0.1 g/ml streptomycin. Flasks were gassed with 10% 
CO* in air and maintained at 37’C for 19 days. The 
culture medium was changed 3 times a week. 
On day 20 of culture, the chondrocytes stopped 
dividing. The medium was replaced with FCS-free 
Dulbecco’s medium. Cells were divided into groups of 
4 identical flasks each (So-100 pg DNA/flask). To 
each flask was added either 0.1% ethanol alone or 
24,25-(OH)zDs (a gift from Dr Uskokovic, Hoffman 
La Roche, Nutley, NJ), or 25-(0H)Ds (a gift from 
.Laboratoires Roussel, Paris). Flasks were placed at 
37’C for an additional 20 h incubation prior to incu- 
bation with the tritiated sterols. 
Cells were gently scraped off, pooled, centrifuged 
at 300 X g for 3 min and resuspended in glass vials 
containing 4 ml Dulbecco’s medium. Each group was 
incubated with 24,25(OH)2 [3H]D3 or, in some 
experiments, with 25-(OH)[3H]Dg. 25(OH)[3H]D3 
(90-100 Ci/mmol) was purchased from Amersham, 
(Versailles) and 24,25(OH)2 [3H] D3 (45-50 
Ci/mmol) was prepared from 25-(OH)[3H]D3 as in 
[l] or purchased from Amersham (Versailles). 
The pure nuclear fractions were then prepared at 
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4°C as in [5 [. Briefly, cells were centrifuged at 
300 X g, rinsed 3 times with GBS and homogenized 
in TSM buffer containing 10 mM Tris-HCl (pH 7.4), 
250 mM sucrose and 1 mM MgCl?. The homogenates 
were centrifuged at 800 X g for 10 min. The resulting 
crude nuclear pellets were rinsed 4 times in TSM 
buffer, each rinse being followed by brief centrifuga- 
tion (800 X g for 10 min). The final pellet was mixed 
with 10 ml 2 M sucrose solution and centrifuged at 
50 000 X g for 60 min in a Sorvall RC 5 centrifuge. 
The resulting purified nuclear pellets were taken up in 
1 ml TSM, rinsed and transferred to TSM containing 
Triton X-100 (1% final cont.), mixed and left for 10 
min at 4°C. The nuclei were then collected and 
washed twice with Triton-free TSM, each wash being 
followed by 2 min centrifugation at 3200 X g. The 
purity of the preparation thus obtained was verified 
by phase contrast microscopy. 
Purified nuclei were suspended in 1 ml methanol- 
chloroform solution (2: 1, v/v) and left for 18 h at 
4’C. They were then centrifuged at 3200 X g for 5 
min. The supernatant was dried, and taken up with 
5 ml Instafluor (Packard). Radioactivity was counted 
during lo-50 min with an SL 30 Intertechnique 
Scintillation Counter with 35% efficiency for tritium. 
DNA content of the pellet (20-40 pg DNA/nuclear 
extract) was assayed according to [6] with calf 
thymus DNA as standard. 
In some experiments, 24,25-(OH)* [3H] Da 
(100 pmol/mg nuclear DNA) was incubated with the 
cultured cells for 20 h. The radioactive pellet was 
then extracted from purified nuclei with 2 ml metha- 
nol and 1 ml chloroform. The chloroform phase was 
dried under nitrogen and redissolved in 150 ~1 
ethanol. An aliquot was then counted and the rest of 
this extract was submitted to high-pressure liquid 
chromatography (Waters Associates, Milford, MA) as 
in [ 11. An aliquot of each fraction of the effluent 
was evaporated, dissolved in 5 ml counting solution 
and counted. The radioactivity recovered in the form 
of 24,25(OH)?Da was evaluated as % of the radio- 
activity applied. 
3. Results 
After 20 h/incubation of 24,25-(0H)2 [3H]DJ with 
cultured chondrocytes, 91% of the radioactivity 
extracted from purified nuclei is recovered in the 
form of 24,25-(OH)2Da by high pressure liquid chro- 
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matography. 24,25-(0H)2 [3H]D3 nuclear uptake is 
therefore expressed in fmol/mg DNA in the following 
experiments. 
3.1. Nuclear uptake of 24,25-(OH)J3HfD3 at 3?C 
or 4°C 
In a set of results for 6 separate experiments, 
cultured chondrocytes, some of which had been prein- 
cubated for 20 h at 37°C with unlabelled 24,25- 
(OH),D, (250 pmol/culture flask, i.e., 10 nmol/mg 
nuclear DNA) were incubated at 37°C for 30 min 
with concentrations of 24,25(0H)2 [‘HID, ranging 
from 2.8 X lo4 to 1.1 X lo6 dpm/flask, i.e., 20-180 
pmol/mg nuclear DNA. Uptake of 24,25(0H)2 [3H]D3 
in purified nuclei (defined as total uptake) increased 
with the 24,25-(0H)2 [3H]D3 concentration in the 
culture medium. For a given concentration, this 
uptake was 49-63% lower in preincubated cells. Since 
further metabolic transformation of 24,25-(OH)2D3 
has not yet been demonstrated in cultured chondro- 
cytes, the 24,25-(OH)2 [3H] Da is defined here as non- 
specific uptake, and the difference between total and 
non-specific uptake, as specific uptake, shown in fig.1. 
No such specific uptake was demonstrated when cells 
were incubated with 24,25-(0H)a [‘HID, at 4°C for 
30 min. 
3.2. Time-course of 24,25-(OH),[ 3HJD3 nuclear 
uptake 
Incubation of 24,25-(0H)2[3H]D3 (100 pmol/mg 
nuclear DNA) at 37°C was studied for various periods. 
Maximumspecific 24,25-(OH)2 [3H]D3 nuclearuptake 
was reached at 30 min and declined considerably by 
240 min (fig.2). The incubation period chosen for 
all further experiments with 24,25-(OH)* [3H]Da was 
therefore 30 min. 
3.3. Specificity of 24,25-(OH)z[3H_lD3 nuclear uptake 
The specificity of the tritiated 24,25(0H)z [3H]Da 
nuclear uptake was measured in cultured chondrocytes 
pre-incubated for 20 h in medium containing 
10 nmol/mg DNA of one of the following: unlabelled 
24,25-(OH)ZD3, 25(OH)D3, 1 ,25(OH)?D3, vitamin 
D3, or progesterone, or sterol-free medium (control 
uptake). Chondrocytes were then incubated for 30 
min at 37’C with 24,25(OH)2 [3H]D3 (350 pmol/mg 
nuclear DNA). Results are shown in table 1. Compared 
to control uptake, there was no apparent decrease in 
24,25-(0H)2 [‘HID 3 in the cells preincubated with 
progesterone or vitamin D3. Preincubation with 1,25- 
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Fig.1. Specific nuclear uptake of 24,25-(0H), [‘HID, in 
cultured chondrocytes incubated with increasing amounts of 
24,25-(OH),[aH]Dg. In this set of 6 separate xpt, cultured 
chondrocytes, some of which had been preincubated for 20 h 
at 37°C with unlabelled 24,25-(OH),D, (250 pmol/ culture 
flask,i.e., 10 nmol/mgnuclear DNA), were incubated at 37°C 
for 30mlnwith24,25-(0H), [‘HID, at 2.8 X 10”-1.1 X lo6 
dpm/flask (20-180 pmol/mg nuclear DNA). For a given con- 
centration, specific uptake is the difference between total 
uptake measured in cells not-preincubated with unlabelled 
24,25-(OH),D, and non-specific uptake measured in cells 
preincubated with unlabelled 24,25-(OH),D,- 
(OH),D, led to a 25%increase in 24,25-(0H)2 [3H]D3 
nuclear uptake, a result which might be the cellular 
reflection of a synergistic effect exerted by 24,25- 
(OH)zD3 and 1 ,25(OH)*D3. Preincubation with 25 
Y I I ,, 1 I 
30 60 ” 120 240 
Incubation time (min) 
Fig.2. Specific nuclear uptake of 24,25-(OH), [sH]D, in 
cultured chondrocytes incubated with this tritiated compound 
(100 pmol/mg nuclear DNA) during 10,30,60,120 or 240 
min at 37°C. For each time studied, specific nuclear uptake 
was calculated as explained in fig. 1 from data obtained in cells 
preincubated or not with non-radioactive 24,25-(OH),D,. 
(OH)D, reduced 24,25-(OH),Da nuclear uptake by 
25%. 
3.4. Nuclear uptake of 2.5-(OH)[3H]D3 
Cultured chondrocytes, whether or not preincu- 
bated with unlabelled 25-(0H)Da (250 nmol/ 
cultured flask), were further incubated with 
25(OH)[3H]D3 (50 or 500 pmol/mg nuclear DNA) 
for 30 min at 37°C. No specific nuclear uptake was 
demonstrated for 25(OH) [3H]D3. The decrease in 
24,25-(OH)2 [3H] Da uptake in cells preincubated 
with 25(OH)Da might therefore have been the result 
of the competition withthe unlabelled 24,25-(OH)*D3 
released by the transformation of 25-(OH)D3 during 
preincubation [ 11. 
Table 1 
Specificity of 24,25-(OH), [aHID, nuclear uptake in purified nuclei from cultured 
rabbit chondrocytes 
Unlabelled sterol in 24,25-(0H), [aHID, nuclear uptake 
preincubation medium (% of control) 
None (control), na = 10 100 
24,25-(OH),D,, n = 5 49-63 (54.5)b 
25-(OH)D,, n = 2 70-80 
1,25-(OH),D,, n = 3 98-160 (125) 
Vitamin D,, n = 1 104 
Progesterone, n = 2 100-100 
a n, number of experiments; b mean uptake is in parentheses 
Chondrocytes were preincubated for 20 h at 37’C with one of the nonradioactive 
sterol(l0 nmol/mg nuclear DNA), or with sterol-free medium (control). They 
were then incubated with 24,25-(OH),[“H]D, for an additional 30 mm at 37°C 
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3.5. Reversibility of 24,25-(OH)J’H]D3 nuclear 
uptake 
We measured the reversibility of the tritiated 
24,25-(OH)* [3H]D 3 nuclear uptake, using cultured 
chondrocytes incubated for 30 min at 37’C with 
24,25-(0H)s [‘HID,. Cells were then transferred either 
to a sterol-free medium or to a medium containing 
non-radioactive 24,25-(OH),D3 (10 nmol/mg nuclear 
DNA) and incubated at 37OC for an additional 
15 min. The 24,25-(OH)sD3 nuclear uptake was 
reversed by 44% when the chondrocytes were trans- 
ferred to a medium containing unlabelled 24,25- 
(OH),D,. When these cells were incubated in control 
sterol-free medium, uptake was only 24% reversible. 
4. Discussion 
Our results indicate that 24,25(OH)2D3 acts in 
cultured rabbit chondrocytes in a similar way to 
steroid hormones in their target cells. Such a result 
therefore provides direct evidence for intrinsic action 
by 24,25-(0H)sDs in these chondrocytes. However, 
24,25-(OH)sD3 is not the only vitamin D metabolite 
active in cartilage in vitro, since we demonstrated ear- 
lier that 1,25(OH)sD3 also increases sulfated proteo- 
glycan synthesis [2] and DNA polymerase activities 
[3]. These chondrocytes therefore appear to be sensi- 
tive to both 24,25(OH)sD3 and 1 ,25-(OH)sD3 at 
concentrations of the same order of magnitude. Such 
sensitivity raises the question of whether or not these 
sterols share a common cellular mechanism in cartilage 
tissue. Our results already support the hypothesis of an 
interrelated mechanism, since preincubation with 1,25- 
(OH)*D3 increased the nuclear uptake of 
24,25-(OH),D,. 
Further experiments are necessary to clarify the 
interaction between 24,25-(OH),D, and 1,25- 
(OH),D,. For this purpose, the chondrocyte model 
seems very suitable, since it allows combined study of 
nuclear sterol binding and the resulting biological 
effects. 
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